Home
Conditions
Neoplasm, Lymphatic Tissue

Clinical trial condition

Neoplasm, Lymphatic Tissue

Explore clinical trials studying Neoplasm, Lymphatic Tissue. Study availability and eligibility vary by location and protocol.

56 public trials 13 recruiting studies

Refine in advanced search Browse all conditions

Neoplasm, Lymphatic Tissue trial results

Completed

Effect of Fasting on the Size of Abdominal Lymphatic Tumors in Women

NCT00552955

Conditions: Ascites, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +27 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Safety Study of Sirolimus and Hydroxychloroquine in Women With Lymphangioleiomyomatosis

NCT01687179

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Brigham and Women's Hospital Boston, Massachusetts, United States

View Trial Details

Completed

The Effect of Lt to Rt Shunt Using Veno-veno-arterial Extracorporeal Membrane Oxygenation (ECMO) on Coronary Oxygenation in Lung Transplantation Patients

NCT02859194

Conditions: ARDS (Acute Respiratory Distress Syndrome), Acute Lung Injury, Bronchial Diseases, +27 more
Locations: Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institue, Yonsei Universiy College of Medicine Seoul, South Korea

View Trial Details

Completed

Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)

NCT00790400

Conditions: Angiomyolipoma, Astrocytoma, Congenital Abnormalities, +43 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Barrow Tuberous Sclerosis Center Phoenix, Arizona, United States

Massachusetts General Hospital Massachussetts General Hospita Boston, Massachusetts, United States

Minnesota Epilepsy Group Saint Paul, Minnesota, United States

View all 25 locations

View Trial Details

Completed

The Tolerability of Saracatinib in Subjects With Lymphangioleiomyomatosis (LAM) (SLAM-1)

NCT02116712

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: University of Cincinnati Cincinnati, Ohio, United States

Baylor College of Medicine Houston, Texas, United States

University of Texas Health Science Center-Houston Houston, Texas, United States

View Trial Details

Completed

Lymphangioleiomyomatosis (LAM) Registry

NCT00005486

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +12 more
Locations: Not specified

View Trial Details

Completed

Pulmonary Rehabilitation in Lymphangioleiomyomatosis

NCT02009241

Conditions: Behavior, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Pulmonary Division, Heart Institute (InCor), University of Sao Paulo Medical School São Paulo, Brazil

View Trial Details

Completed

Doxycycline In Lymphangioleiomyomatosis (LAM)

NCT00989742

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +23 more
Locations: Nottingham University Hospitals Nottingham, United Kingdom

View Trial Details

Completed

Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors

NCT00413322

Conditions: Adenoma, Adenosarcoma, Adnexal Diseases, +92 more
Locations: Mayo Clinic Arizona Scottsdale, Arizona, United States

University of Nebraska Omaha, Nebraska, United States

Portsmouth Regional Hospital Hematology/Oncology Clinic Portsmouth, New Hampshire, United States

View Trial Details

Completed

A Study to Evaluate Sildenafil for the Treatment of Lymphatic Malformations

NCT01290484

Conditions: Cardiovascular Abnormalities, Cardiovascular Diseases, Congenital Abnormalities, +9 more
Locations: Stanford University School of Medicine Stanford, California, United States

View Trial Details

Neoplasm, Lymphatic Tissue

Neoplasm, Lymphatic Tissue trial results

Related conditions